July 2024 | AIChE

You are here

July 2024

Simone Bruno

Simone Bruno, Ph.D. is a Postdoctoral Fellow in the lab of Prof. Franziska Michor, with a dual affiliation at the Department of Data Science at Dana-Farber Cancer Institute and the Department of Stem Cell and Regenerative Biology at Harvard University. His research focuses on developing, analyzing, and validating mathematical models of complex dynamical systems, particularly in the context of chromatin modification dynamics and epigenetics. The goal is to gain a mechanistic understanding of how chromatin modifications affect cell memory and how this, in turn, influences biological...Read more

Majid Pahlevan Kakhki

Dr. Majid Pahlevan Kakhki is a senior postdoctoral fellow in Prof. Maja Jagodic's group at the Department of Clinical Neuroscience, Karolinska Institutet. His research focuses on advancing the field of translational neuroimmunology by using innovative genetic and molecular approaches, with an emphasis on epigenetics, to understand the mechanisms underlying neuroinflammation and neurodegeneration, mainly in Multiple Sclerosis (MS). His work integrates cutting-edge methodologies in molecular and cellular neuro-epigenetics, within a clinical framework, utilizing one of the world's most...Read more

Michael Herschl



Michael Herschl is a 5th year Ph.D. candidate in the UCSF-UC Berkeley Joint Program in Bioengineering. He develops high-throughput techniques to study epigenetic interactions and develop new combinatorial epigenome editors in the lab of Professor Patrick Hsu at the Arc Institute in Palo Alto, CA. He earned his Bachelor's Degree in Bioengineering from Stanford University in 2019, where he studied the spreading of chromatin-mediated gene silencing in the lab of Professor Lacra Bintu. After completing his Ph.D., Michael hopes to develop next-generation cellular therapeutics to...Read more

Marvin Tanenbaum



Marvin Tanenbaum received his PhD in 2010 Cum Laude from Utrecht University for his work on cell division in the group of Prof. René Medema. After obtaining his PhD, he was a postdoc in the group of Prof. Ron Vale at UCSF from 2011-2015, where he developed a keen interest in the mechanisms and dynamics of gene expression control. He pioneered several new techniques, including the SunTag system, and contributed to the development of CRISPR activation (CRISPRa), a method to increase expression of endogenous genes. In 2015, he became a group leader at the Hubrecht Institute in the...Read more

Samuel Reisman



Sam Reisman is a PhD candidate in Cell Biology at Duke University. His research focuses on utilizing high-throughput genome and epigenome editing tools to understand and engineer cell fate specification in the brain. Before starting his PhD, he worked in science education and outreach, building cell biology museum exhibits at the Exploratorium in San Francisco. ...Read more

Matthew Meiners



Matt Meiners is the Senior Director of Production at EpiCypher. He received his PhD in from the University of North Carolina at Chapel Hill. Over the past 10 years, he has led EpiCypher’s efforts in the generation of nucleosome substrates and nucleosome-based technologies. His current work at EpiCypher is exploring more efficient ways to generate, detect, and report on epigenetic modifications and map their locations....Read more

Conrad Johnston

Dr. Johnston is an applied scientist at Microsoft in the Azure Quantum Elements team. In this role, Conrad develops new computational workflows and accelerates customers' adoption of computational tools and techniques. His PhD is in computational condensed matter physics, but his research has also ventured into the related fields of computational chemistry and computational biology. Before joining Microsoft, Conrad held postdoctoral positions at Pacific Northwest National Laboratory in the US, EPFL in Switzerland, and Queen's University Belfast in the UK. He's passionate about lowering the...Read more

Paulina Velasquez



Paulina Velasquez, MD. Is an Associate Member in the Department of Bone Marrow Transplantation and Cell Therapy (BMTCT). She received her MD from Universidad Francisco Marroquin in Guatemala and then went on to train in Pediatrics and Pediatric Hematology Oncology at Baylor College of Medicine. She joined St. Jude Children’s Research Hospital in 2017.

As a physician scientist, she is focused on preclinical development of immunotherapeutic strategies for high-risk hematological malignancies. Her work centers on antigen discovery, multiantigen targeting, and addressing...Read more

Pages